Back to results
US 2012/0238598 A1Published application
Derivatives of 7 alkynyl-1,8 naphthyridones, preparation method thereof and use of same in therapeutics
AssigneeSanofi-Aventis
InventorsAntoine ALAM, Françoise BONO, Oliver DUCLOS, Gary MCCORT
Life of this patent
Estimating the term…
Abstract
The disclosure relates to method of treating a disease in which VEGFR-3 is involved, comprising administering a therapeutically effective amount of a compound of the formula wherein R1, R2, R3, and R4 are as defined in the disclosure, to compositions containing them, to processes for preparing them, and to their use in therapeutics.
Claims8
A method treating a disease selected from the group consisting of restenosis, nephrosclerosis, and liver cirrhosis, comprising administering to a patient in need thereof an effective dose of a compound of formula (I):
- wherein:
- R1 and R2 represent, independently of one another:
- a hydrogen atom, or
- a C1-C7 alkyl group optionally substituted by one or more alkoxy groups;
- R3 represents a C1-C7 alkyl group;
- R4 represents a hydrogen atom or a C1-C4 alkyl group;
- Y represents a C1-C4 alkoxy group or an —NRR′ or —O(CH2)n—C(O)—NRR′ group where R and R′ are as defined below and n is an integer equal to 1 or 2;
- R″ represents a C1-C4 alkyl group;
- and
- R and R′ represent, independently of one another, a hydrogen atom, a —CO—(C1-C4 alkyl) group or a —COOR″ group, where R″ is as defined above;
- or an acid addition salt thereof, or an enantiomer or diastereoisomer thereof, or a mixture thereof.
8 more elements
Dependencies are inferred from the claim text.